Obsidian Therapeutics, Inc. (OBX) Balance Sheet
OBX balance sheet, 2025
December 31, 2025 · U.S. dollars$88.6M assets = $354.6M liabilities + −$266.0M equity
Liabilities exceed assets: shareholders’ equity is negative (−$266.0M).
Both columns are drawn to the same scale: what OBX owns equals what it owes plus shareholders’ equity. Hover a block for its value.
OBX financial health
Descriptive bands, not a rating. Fiscal 2025.
OBX balance sheet trends, 2024–2025
| Metric | Trend | Then | Latest | Change |
|---|---|---|---|---|
| Total assets | $183.7M2024 | $88.6M2025 | −51.8%/yr | |
| Total liabilities | $358.1M2024 | $354.6M2025 | −1.0%/yr | |
| Shareholders’ equity | −$174.4M2024 | −$266.0M2025 | — | |
| Cash & short-term investments | $168.3M2024 | $80.5M2025 | −52.2%/yr | |
| Working capital | $156.8M2024 | $66.2M2025 | −$90.6M | |
| Book value per share | −$2.832024 | −$4.322025 | — | |
| Current ratio | 10.752024 | 5.312025 | −5.44 | |
| Shares outstanding | 61.6M2024 | 61.6M2025 | 0.0%/yr |
Change is the average annual growth (CAGR) or the difference between the first and latest year.
OBX assets
OBX liabilities and equity
OBX debt vs cash
Debt includes short- and long-term borrowings and, where reported, lease obligations.
OBX balance sheet
| 2025 | 2024 | |
|---|---|---|
| Assets | ||
| Cash & short-term investments | $80.5M | $168.3M |
| Cash & equivalents | $40.4M | $49.8M |
| Short-term investments | $40.1M | $118.5M |
| Receivables | $0 | $0 |
| Inventory | $0 | $0 |
| Other current assets | $1.0M | $4.6M |
| Total current assets | $81.5M | $172.8M |
| Property, plant & equipment (net) | $6.1M | $9.9M |
| Goodwill & intangible assets | $0 | $0 |
| Long-term investments | $0 | $0 |
| Other non-current assets | $1.0M | $1.0M |
| Total assets | $88.6M | $183.7M |
| Liabilities | ||
| Accounts payable | $12,000 | $1.8M |
| Total current liabilities | $15.4M | $16.1M |
| Long-term debt | $0 | $0 |
| Lease obligations | $4.3M | $6.8M |
| Other long-term liabilities | $339.3M | $342.1M |
| Total liabilities | $354.6M | $358.1M |
| Shareholders' equity | ||
| Retained earnings (deficit) | −$295.9M | −$195.3M |
| Total shareholders' equity | −$266.0M | −$174.4M |
| Key figures | ||
| Working capital | $66.2M | $156.8M |
| Tangible book value | −$266.0M | −$174.4M |
| Book value per share | −$4.32 | −$2.83 |
| Shares outstanding | 61.6M | 61.6M |
| Current ratio | 5.31 | 10.75 |
| Quick ratio | 5.24 | 10.46 |
| Equity / assets | −300.3% | −94.9% |
| Mar '26 | |
|---|---|
| Assets | |
| Cash & short-term investments | $58.8M |
| Cash & equivalents | $26.4M |
| Short-term investments | $32.3M |
| Receivables | $0 |
| Inventory | $0 |
| Other current assets | $5.3M |
| Total current assets | $64.0M |
| Property, plant & equipment (net) | $5.1M |
| Goodwill & intangible assets | $0 |
| Long-term investments | $0 |
| Other non-current assets | $1.0M |
| Total assets | $70.1M |
| Liabilities | |
| Accounts payable | $738,000 |
| Total current liabilities | $15.2M |
| Long-term debt | $0 |
| Lease obligations | $3.6M |
| Other long-term liabilities | $331.1M |
| Total liabilities | $346.3M |
| Shareholders' equity | |
| Retained earnings (deficit) | −$315.6M |
| Total shareholders' equity | −$276.2M |
| Key figures | |
| Working capital | $48.8M |
| Tangible book value | −$276.2M |
| Book value per share | −$4.48 |
| Shares outstanding | 61.6M |
| Current ratio | 4.21 |
| Quick ratio | 3.86 |
| Equity / assets | −393.8% |
Quarterly columns are labeled by the month the quarter ended. Figures in U.S. dollars as reported (latest annual report filed —); data from EODHD.
OBX financial position
At the end of fiscal 2025 (December 31, 2025), Obsidian Therapeutics had total assets of $88.6 million (down 51.8% from a year earlier), total liabilities of $354.6 million and shareholders' equity of -$266.0 million. Its current ratio was 5.31. In the latest quarter (ended March 31, 2026) total assets were $70.1 million and equity -$276.2 million.
Related: OBX income statement, OBX cash flow statement, OBX key metrics. See the OBX stock overview for the latest quote and news.
OBX balance sheet FAQ
What are Obsidian Therapeutics's total assets?
Obsidian Therapeutics reported total assets of $88.6 million at the end of fiscal 2025 (December 31, 2025), compared with $183.7 million a year earlier.
How much cash does Obsidian Therapeutics have?
Obsidian Therapeutics held $80.5 million in cash and short-term investments at the end of fiscal 2025.
What is Obsidian Therapeutics's book value?
Obsidian Therapeutics's shareholders' equity (book value) was -$266.0 million at the end of fiscal 2025, or −$4.32 per share.
What is Obsidian Therapeutics's current ratio?
Obsidian Therapeutics had current assets of $81.5 million and current liabilities of $15.4 million, a current ratio of 5.31 (it can cover its short-term obligations).